中文 | English
Return
Total: 1216 , 1/122
Show Home Prev Next End page: GO
Author:( Ming SHAO)

3.Review of biosimilar regulatory guidelines and scientific principles:Experiences from Europe-an Medicines Agency (EMA) guidelines

Ming CHEN ; Rong SHAO

Chinese Journal of Health Policy 2014;(10):21-26

4. Analysis of microsatellite instability and loss of heterozygosity in thymoma

Ming-Hai SHAO

Tumor 2008;28(1):57-60

5.The clinical observation of Chinese medicine on TPOAb, TGAb of the patients with Hashimoto's thyroiditis

Ming DU ; Hong WANG ; Yingxin SHAO

International Journal of Traditional Chinese Medicine 2014;(5):419-421

6.Reliability and validity of the Chinese version of Interpersonal Stress-Coping Inventory for undergraduates

Ming LI ; Shuqin PANG ; Wei SHAO

Chinese Mental Health Journal 2010;24(1):55-58

7.Syndrome analysis on patients of chronic hepatitis B treated by Lamivudine

Lingfeng WAN ; Hongbing ZHAO ; Ming SHAO

International Journal of Traditional Chinese Medicine 2011;33(2):146-148

8.Genotypes of human papilloma virus in male condyloma acuminata patients in Lishui area.

Hai-ming NING ; Shao-fang WU

National Journal of Andrology 2015;21(11):1001-1004

9.Quantitative determination of Ophiopogonin D in Zhe Ophiopogon japonicus(Thunb.)Ker-Gawl. and Chuan Ophiopogon japonicus(Thunb.) Ker-Gawl. by HPLC-ELSD

Jianpin YU ; Jianfeng SHAO ; Ming ZHU

Traditional Chinese Drug Research & Clinical Pharmacology 1993;0(04):-

10.Research advances in traditional Chinese medicine treatment for primary liver cancer

Huixian SONG ; Fei QIAO ; Ming SHAO

Journal of Clinical Hepatology 2016;32(1):174-177

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1216 , 1/122 Show Home Prev Next End page: GO